ACADIA PHARMACEUTICALS INC — Director's Dealing 2016

Apr 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2016-04-07

Reporting Person: GRAY MARY ANN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-07	Common Stock	M	10000	$1.30	Acquired	10000	Direct
2016-04-07	Common Stock	M	57692	$1.30	Acquired	67692	Direct
2016-04-07	Common Stock	M	55147	$1.36	Acquired	122839	Direct
2016-04-07	Common Stock	M	10000	$1.36	Acquired	132839	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-07	Stock option (right to buy)	$1.30	M	10000	Disposed	2020-06-10	Common Stock (10000)	Direct
2016-04-07	Stock option (right to buy)	$1.30	M	57692	Disposed	2020-06-10	Common Stock (57692)	Direct
2016-04-07	Stock option (right to buy)	$1.36	M	55147	Disposed	2022-06-07	Common Stock (55147)	Direct
2016-04-07	Stock option (right to buy)	$1.36	M	10000	Disposed	2022-06-07	Common Stock (10000)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of June 11, 2010.

F2: 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of June 8, 2012.